About Moderna, Inc.
Moderna is an American pharmaceutical and biotechnology company with headquarters in Massachusetts. Moderna rose to prominence during the Covid-19 pandemic as a primary candidate for the development of a vaccine, which was then authorised for distribution to the public across multiple countries at the start of 2021. Moderna’s work focuses on drug discovery and development, with a heavy emphasis on artificial mRNA cells. Moderna stock is listed on the NASDAQ exchange and it is also a constituent of the NASDAQ 100 index, which is a modified measure of the top 100 non-financial companies in the US on the exchange. Spread bet or trade CFDs on our Moderna share price.
Why trade Moderna, Inc. with CMC Markets?
We've invested over £100m into our trading platform, creating pioneering technology that puts powerful software in your hands.
Set your default position size and enter with a single 'click'.
99.9% fill rate with 0.0029s execution*
Wherever possible we fill your trade and always at the price you see.
99.95%+ platform stability**
We consistently achieve core platform uptime, allowing you to focus on your trading.
We crunch 225m prices every day, from up to 14 feeds from tier one liquidity providers.